leisure time -WSS

leisure time

author：comprehensive 2025-10-01 20:14:57 - browse：56

The experimental Alzheimer’s drug lecanemab, hailed after it slowed patients’ cognitive decline in a clinical trial, may have contributed to the death in June of a patient in the study, STAT has learned.

One investigator on the study flagged the death, noting it came after the patient experienced bleeding in the brain, and concluded it was related to the drug, according to documents obtained by STAT. Eisai, the drugmaker behind lecanemab, disagreed, pointing to other possible factors, including a series of setbacks in preceding months — multiple falls, a heart attack, a respiratory infection, and mini-stroke-like events.

Though still under investigation, the death suggests that new medicines to treat Alzheimer’s, like medicines to treat anything else, will come with their own side effects and costs. It also raises the importance of waiting for the full lecanemab data before drawing conclusions based on the positive press release put out by Eisai and its partner Biogen last month.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： 2 million sign

leisure time

WSS

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

Close Medicare's dangerous gaps in addiction treatment coverage

Key Senate committee drafts bipartisan bill to stem drug shortages

Diversity in clinical trials starts with building trust, experts say

Why rehabilitation engineers need to center patients in their research

3 protesters arrested at Wimbledon after interrupting matches by throwing confetti on court

Wikipedia

leisure time

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

Tori Bowie and the unacceptable rates of Black maternal death

Diversity in clinical trials starts with building trust, experts say

Cancer drug shortages should be causing more outrage

Orangutan used medicinal plant to treat wound, first time ever seen

Tori Bowie and the unacceptable rates of Black maternal death

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Guidelines to prevent youth baseball injuries need more muscle

Melinda French Gates resigns from Gates Foundation

entertainment

Getting Alzheimer's drug Leqembi to patients can be a challenge

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

China dismisses criticism of top diplomat's comments appearing to push for race

5 shark bites reported on Long Island as officials deploy surveillance drones

Element Biosciences CEO lays out genome sequencing strategy

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

knowledge

leisure time

hotspot

Wikipedia